{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:00:08Z","timestamp":1792738808400,"version":"4.5.0"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>\nBackground\n<\/jats:title>\n<jats:p>The effect of different concentrations of heparin-locking solution for central venous catheters (CVC) in hemodialysis patients is varied. Regarding the optimal concentration of heparin-locking solution, there is no definitive consensus based on evidence.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>\nObjective\n<\/jats:title>\n<jats:p>To investigate the efficacy and safety of different concentrations of heparin for CVC locking in hemodialysis patients.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>\nMethods\n<\/jats:title>\n<jats:p>We searched PubMed, Embase, Web of science, the Cochrane Library and Clinical Trial Database (clinicaltrials.gov) from establishment of each database to September 19, 2024 for randomized control trials (RCTs), non-randomized control trials (NRCTs) and cohort study of heparin-locking solution for CVC in hemodialysis patients aged \u2265\u200918 years. Outcome data regarding catheter occlusion, hemodialysis blood flow, bleeding-related complications, catheter-related infection, and catheter retention time were extracted and pooled from selected studies. The quality of included RCTS, cohort studies, and NRCT were assessed using bias risk tools recommended in the Cochrane Handbook. A fixed-effect model was used to calculate pooled odds ratios or mean differences with 95% confidence intervals.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>\nResults\n<\/jats:title>\n<jats:p>Three RCTs, three cohort studies and one NRCT involving 946 hemodialysis patients were included. Heparin-locking solution of 1000 U\/ml reduces the occurrence of bleeding related complications (OR =\u2009 0.20, 95%CI: 0.05-0.79, P\u2009= 0.02) compared to 5000 U\/ml and 10000 U\/ml. No significant difference was observed in hemodialysis blood flow (MD\u2009=\u2009-6.95, 95% CI: -14.41- 0.51, P\u2009=\u20090.07), catheter occlusion (OR =\u2009 0.89, 95% CI =\u2009 0.60-1.33, P\u2009= 0.58), catheter retention time (MD\u2009=\u2009-0.16, 95% CI: -1.98 \u2013 1.67, P\u2009=\u20090.87), and catheter-related infection (OR\u2009=\u20090.60, 95%CI: 0.31-1.19, P\u2009=\u20090.14).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec005\">\n<jats:title>\nConclusion\n<\/jats:title>\n<jats:p>Our findings suggest that a heparin-locking solution at a concentration of 1000 U\/ml for central venous catheters (CVC) in hemodialysis patients may reduce the incidence of bleeding-related complications, without impacting the rates of catheter occlusion, hemodialysis blood flow, catheter retention time, or catheter-related infections. However, due to the limited number of included studies, high-quality randomized controlled trials and cohort studies with long-term follow-up are warranted to further validate these results.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0320207","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T22:54:40Z","timestamp":1742943280000},"page":"e0320207","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effect of different concentrations of heparin-locking solution for central venous catheters in hemodialysis patients: A systematic review and meta-analysis"],"prefix":"10.1371","volume":"20","author":[{"given":"Lin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5730-8172","authenticated-orcid":true,"given":"Yuwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0387-307X","authenticated-orcid":true,"given":"Yuxiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"issue":"3","key":"pone.0320207.ref001","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/svms.2000.18297","article-title":"Hemodialysis","volume":"15","author":"DA Elliott","year":"2000","journal-title":"Clin Tech Small Anim Pract"},{"issue":"1","key":"pone.0320207.ref002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nefroe.2022.03.006","article-title":"Clinical and ultrasound evaluation for hemodialysis access creation","volume":"42","author":"A Lima","year":"2022","journal-title":"Nefrologia (Engl Ed)"},{"issue":"10","key":"pone.0320207.ref003","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41581-020-0315-4","article-title":"The current and future landscape of dialysis","volume":"16","author":"J Himmelfarb","year":"2020","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"pone.0320207.ref004","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.ajkd.2019.12.001","article-title":"KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update","volume":"75","author":"CE Lok","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"pone.0320207.ref005","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/hdi.12472","article-title":"Heparin albumin priming in a clinical setting for hemodialysis patients at risk for bleeding","volume":"21","author":"M Skagerlind","year":"2017","journal-title":"Hemodial Int"},{"issue":"4","key":"pone.0320207.ref006","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1053\/j.ajkd.2018.10.014","article-title":"Complications from tunneled hemodialysis catheters: a Canadian observational cohort study","volume":"73","author":"K Poinen","year":"2019","journal-title":"Am J Kidney Dis Official J National Kidney Found"},{"issue":"Suppl 2","key":"pone.0320207.ref007","doi-asserted-by":"crossref","first-page":"ii51","DOI":"10.1093\/ndt\/gfaa005","article-title":"The renal replacement therapy landscape in 2030: reducing the global cardiovascular burden in dialysis patients","volume":"35","author":"B Canaud","year":"2020","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"pone.0320207.ref008","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1080\/0886022X.2022.2118068","article-title":"Reevaluation of lock solutions for Central venous catheters in hemodialysis: a narrative review","volume":"44","author":"Y Wang","year":"2022","journal-title":"Ren Fail"},{"issue":"2","key":"pone.0320207.ref009","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/ndt\/gfl606","article-title":"Sodium citrate 4% locking solution for central venous dialysis catheters--an effective, more cost-efficient alternative to heparin","volume":"22","author":"L Grudzinski","year":"2007","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"pone.0320207.ref010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5414\/CN108701","article-title":"Low-dose versus high-dose heparin locks for hemodialysis catheters: a systematic review and meta-analysis","volume":"86","author":"X Han","year":"2016","journal-title":"Clin Nephrol"},{"issue":"1","key":"pone.0320207.ref011","doi-asserted-by":"crossref","first-page":"e12907","DOI":"10.1111\/ijn.12907","article-title":"Heparin locks with low and high concentration in haemodialysis patients: a systematic review and meta-analysis","volume":"27","author":"J Tan","year":"2021","journal-title":"Int J Nurs Pract"},{"issue":"2","key":"pone.0320207.ref012","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/nep.12354","article-title":"Effect of ultra-low dose and standard heparin locks on early tunnelled dialysis catheter outcomes in low-risk dialysis patients","volume":"20","author":"CJ Renaud","year":"2015","journal-title":"Nephrology (Carlton)"},{"issue":"3","key":"pone.0320207.ref013","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/hdi.12401","article-title":"Low dose heparin lock (1000 U\/mL) maintains tunnelled hemodialysis catheter patency when compared with high dose heparin (5000 U\/mL): a randomised controlled trial","volume":"20","author":"G Chu","year":"2016","journal-title":"Hemodial Int"},{"key":"pone.0320207.ref014","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"A Liberati","year":"2009","journal-title":"BMJ (Clinical research ed)"},{"issue":"9","key":"pone.0320207.ref015","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"A Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"pone.0320207.ref016","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"JA Sterne","year":"2016","journal-title":"BMJ"},{"key":"pone.0320207.ref017","unstructured":"Tufanaru C, Munn Z, Stephenson M, Aromataris E. Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness. (1744-1609 (Electronic)"},{"key":"pone.0320207.ref018","first-page":"241","article-title":"Analysing data and undertaking meta-analyses","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"on behalf of the Cochrane Statistical Methods G","year":"2019"},{"issue":"4","key":"pone.0320207.ref019","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/MAT.0b013e3180619519","article-title":"Concentration of heparin-locking solution and risk of central venous hemodialysis catheter malfunction","volume":"53","author":"CM Thomas","year":"2007","journal-title":"ASAIO J"},{"issue":"4","key":"pone.0320207.ref020","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1525-139X.2007.00294.x","article-title":"Concentrated heparin lock is associated with major bleeding complications after tunneled hemodialysis catheter placement","volume":"20","author":"A Yevzlin","year":"2007","journal-title":"Sem Dial"},{"issue":"8","key":"pone.0320207.ref021","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.2215\/CJN.01230210","article-title":"Does the heparin lock concentration affect hemodialysis catheter patency?","volume":"5","author":"DM Ivan","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"pone.0320207.ref022","doi-asserted-by":"crossref","first-page":"212","DOI":"10.5414\/CN106460","article-title":"The effect of heparinized catheter lock solutions on systemic anticoagulation in hemodialysis patients","volume":"75","author":"P Thomson","year":"2011","journal-title":"Clin Nephrol"},{"issue":"3","key":"pone.0320207.ref023","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000328743","article-title":"Low-dose heparin retention in temporary hemodialysis double-lumen catheter does not increase catheter occlusion and might reduce risk of bleeding","volume":"32","author":"H-H Hu","year":"2011","journal-title":"Blood Purif"},{"issue":"3","key":"pone.0320207.ref024","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s11255-012-0151-y","article-title":"Low concentration of heparin used for permanent catheters canal locking is effective and diminishes the risk of bleeding","volume":"45","author":"T Hryszko","year":"2013","journal-title":"Int Urol Nephrol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0320207","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T22:55:23Z","timestamp":1742943323000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0320207"}},"subtitle":[],"editor":[{"given":"Ey\u00fcp Serhat","family":"\u00c7al\u0131k","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0320207","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]}}}